Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

AGE metabolites: a biomarker linked to cancer disparity?

Foster D, Spruill L, Walter KR, Nogueira LM, Fedarovich H, Turner RY, Ahmed M, Salley JD, Ford ME, Findlay VJ, Turner DP.

Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):2186-91. doi: 10.1158/1055-9965.EPI-14-0564. Epub 2014 Jul 22.

2.

Advanced glycation end-products: a biological consequence of lifestyle contributing to cancer disparity.

Turner DP.

Cancer Res. 2015 May 15;75(10):1925-9. doi: 10.1158/0008-5472.CAN-15-0169. Epub 2015 Apr 28. Review.

3.

Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP.

Kyung SY, Byun KH, Yoon JY, Kim YJ, Lee SP, Park JW, Lee BH, Park JS, Jang AS, Park CS, Jeong SH.

Int J Clin Exp Pathol. 2013 Dec 15;7(1):221-8. eCollection 2014.

4.

Biological factor may be linked to prostate cancer racial disparities.

Printz C.

Cancer. 2014 Apr 15;120(8):1132-3. doi: 10.1002/cncr.28692. No abstract available.

5.

Novel Biomarker Signature That May Predict Aggressive Disease in African American Men With Prostate Cancer.

Yamoah K, Johnson MH, Choeurng V, Faisal FA, Yousefi K, Haddad Z, Ross AE, Alshalafa M, Den R, Lal P, Feldman M, Dicker AP, Klein EA, Davicioni E, Rebbeck TR, Schaeffer EM.

J Clin Oncol. 2015 Sep 1;33(25):2789-96. doi: 10.1200/JCO.2014.59.8912. Epub 2015 Jul 20.

6.

Advanced glycation end products (AGE) induce the receptor for AGE in the colonic mucosa of azoxymethane-injected Fischer 344 rats fed with a high-linoleic acid and high-glucose diet.

Shimomoto T, Luo Y, Ohmori H, Chihara Y, Fujii K, Sasahira T, Denda A, Kuniyasu H.

J Gastroenterol. 2012 Oct;47(10):1073-83. doi: 10.1007/s00535-012-0572-5. Epub 2012 Mar 31.

PMID:
22467055
7.

Advanced glycation end products, soluble receptor for advanced glycation end products, and risk of colorectal cancer.

Jiao L, Taylor PR, Weinstein SJ, Graubard BI, Virtamo J, Albanes D, Stolzenberg-Solomon RZ.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1430-8. doi: 10.1158/1055-9965.EPI-11-0066. Epub 2011 Apr 28.

8.

The Role of Advanced Glycation End-Products in Cancer Disparity.

Turner DP.

Adv Cancer Res. 2017;133:1-22. doi: 10.1016/bs.acr.2016.08.001. Epub 2016 Oct 12.

PMID:
28052818
9.

Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men.

Wu AH, Whittemore AS, Kolonel LN, Stanczyk FZ, John EM, Gallagher RP, West DW.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):533-8.

10.

Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals.

Platz EA, Rimm EB, Willett WC, Kantoff PW, Giovannucci E.

J Natl Cancer Inst. 2000 Dec 20;92(24):2009-17.

PMID:
11121463
11.

Prostate cancer and African-American men.

Powell IJ.

Oncology (Williston Park). 1997 May;11(5):599-605; discussion 606-15 passim. Review.

12.

Tumor immunobiological differences in prostate cancer between African-American and European-American men.

Wallace TA, Prueitt RL, Yi M, Howe TM, Gillespie JW, Yfantis HG, Stephens RM, Caporaso NE, Loffredo CA, Ambs S.

Cancer Res. 2008 Feb 1;68(3):927-36. doi: 10.1158/0008-5472.CAN-07-2608.

13.

Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patients.

Asbell SO, Raimane KC, Montesano AT, Zeitzer KL, Asbell MD, Vijayakumar S.

J Natl Med Assoc. 2000 Sep;92(9):445-9.

14.

ROBO1, a tumor suppressor and critical molecular barrier for localized tumor cells to acquire invasive phenotype: study in African-American and Caucasian prostate cancer models.

Parray A, Siddique HR, Kuriger JK, Mishra SK, Rhim JS, Nelson HH, Aburatani H, Konety BR, Koochekpour S, Saleem M.

Int J Cancer. 2014 Dec 1;135(11):2493-506. doi: 10.1002/ijc.28919. Epub 2014 Apr 29.

15.

[Correlation of the expressions of advanced glycation end products and its receptor in serum and placenta with the pathogenesis of preeclampsia].

Xian N, Chen W, Zhang Y, Li J, Zhang N, Ye Y.

Zhonghua Fu Chan Ke Za Zhi. 2015 Jul;50(7):493-9. Chinese.

PMID:
26311638
16.

Enhanced expression of SOS1 is detected in prostate cancer epithelial cells from African-American men.

Timofeeva OA, Zhang X, Ressom HW, Varghese RS, Kallakury BV, Wang K, Ji Y, Cheema A, Jung M, Brown ML, Rhim JS, Dritschilo A.

Int J Oncol. 2009 Oct;35(4):751-60.

17.

Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.

Ishiguro H, Nakaigawa N, Miyoshi Y, Fujinami K, Kubota Y, Uemura H.

Prostate. 2005 Jun 15;64(1):92-100.

PMID:
15666359
18.

Altered N-myc downstream-regulated gene 1 protein expression in African-American compared with caucasian prostate cancer patients.

Caruso RP, Levinson B, Melamed J, Wieczorek R, Taneja S, Polsky D, Chang C, Zeleniuch-Jacquotte A, Salnikow K, Yee H, Costa M, Osman I.

Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):222-7.

19.

African-American Men with Gleason Score 3+3=6 Prostate Cancer Produce Less Prostate Specific Antigen than Caucasian Men: A Potential Impact on Active Surveillance.

Kryvenko ON, Balise R, Soodana Prakash N, Epstein JI.

J Urol. 2016 Feb;195(2):301-6. doi: 10.1016/j.juro.2015.08.089. Epub 2015 Sep 2.

PMID:
26341575
20.

RAGE influences obesity in mice. Effects of the presence of RAGE on weight gain, AGE accumulation, and insulin levels in mice on a high fat diet.

Leuner B, Max M, Thamm K, Kausler C, Yakobus Y, Bierhaus A, Sel S, Hofmann B, Silber RE, Simm A, Nass N.

Z Gerontol Geriatr. 2012 Feb;45(2):102-8. doi: 10.1007/s00391-011-0279-x.

PMID:
22350391

Supplemental Content

Support Center